-
Structure-activity and structure-property relationships of antimalarial pyrimido[1,2-a]benzimidazoles, imidazo[1,2-a]pyridines, and imidazo[1,2-a]pyrimidines
-
Physicochemical, biological and β-haematin inhibiting activity of pyrido-dibemequines, pyrido[1,2-α]benzimidazoles and their derivatives
-
Synthesis, pharmacological and solubility evaluation of antiplasmodial pyrido[1,2-a]benzimidazoles with cyclic and functionalized amine side chain substituents
-
Synthesis, pharmacological and physicochemical profiling of antimalarial and antischistosomal N-aryl 3-trifluoromethyl pyrido [1,2-α] benzimidazoles
-
The synthesis and evaluation of new organometallic benzimidazole Complexes as antiplasmodials
-
Synthesis, physicochemical and biological evaluation of N-dealkylated metabolites of antimalarial pyrido[1,2-a]benzimidazoles and related compounds containing a Mannich base side-chain
-
Synthesis and profiling of antimalarial side-chain modified pyrido[1,2-a]benzimidazoles
-
Synthesis, structure-activity relationship and solubility improvement studies of potential antimalarial and antischistosomal pyrido[1,2-a]benzimidazoles
-
Synthesis and biological evaluation of benzimidazole-linked 1,2,3-triazole congeners as agents
-
The synthesis and study of novel ferrocenyl-benzimidazole derivatives as antiplasmodial agents
-
Synthesis and biological evaluation of trimeric 2,5-disubstituted benzimidazoles and related trinuclear ruthenium(II) organometallic complexes
-
Synthesis of 2,2-dipyridylamine organometallic complexes for antiplasmodial application
-
Antimycobacterial 2-aminoquinazolinones and benzoxazole-based oximes: synthesis, biological evaluation, physicochemical profiling and supramolecular derivatization
-
Mono- and polynuclear Ferrocenyl-derived complexes: synthesis, characterisation and biological evaluation as
antimycobacterial and antiplasmodial agents
-
Synthesis and investigation of benzimidazole and carbazole ß-haematin inhibiting scaffolds with antimalarial activity
-
Synthesis and antiplasmodial structure-activity relationships for some novel 4-aminoquinolines and 5-chlorobenzimidazoles
-
Piperazine-based pyrido[1,2-a]benzimidazoles: synthesis and pharmacological evaluation as potential antimalarial and antischistosomal agents
-
Structure-activity relationship studies of 2-phenylbenzimidazoles and related organometallic complexes as antiplasmodial agents
-
Antiplasmodial neolignans from Trema orientalis : identification, synthesis and analogue generation.
-
Mono- and multinuclear PGM complexes containing thiosemicarbazones synthesis, characterization and antiplasmodial evaluation
-
Synthesis and characterization of 1,2-epoxybutane polymers and their urethane elastomers
-
Quinoline-triazole half-sandwich iridium(III) complexes: Synthesis, antiplasmodial activity and preliminary transfer hydrogenation studies
-
Polydopamine-Functionalized Zinc Oxide Nanoparticles as a Root Canal Sealer: Characterization, Biological, and Physicochemical Properties
-
The application of the Multi-Component Reaction (MCR) strategy in the design and synthesis of new antiplasmodial and antimycobacterial agents
-
Synthesis and biological evaluation of thiazole and metergoline derivatives as antimycobacterial and antiplasmodial agents
-
Synthesis, structure-activity relationship and solubility improvement studies of potential antimalarial and antischistosomal pyrido[1,2-a]benzimidazoles
-
Small molecule inhibitors of parasitic enzymes
-
Antiplasmodial neolignans from Trema orientalis : identification, synthesis and analogue generation.
-
Synthesis, pharmacological and physicochemical profiling of antimalarial and antischistosomal N-aryl 3-trifluoromethyl pyrido [1,2-α] benzimidazoles
-
Design, synthesis and evaluation of potential dual drugs targeting the haemoglobin degradation pathway in the malaria parasite Plasmodium falciparum
-
Synthesis and profiling of antimalarial side-chain modified pyrido[1,2-a]benzimidazoles
-
Synthesis of aminomethylthiazole analogues for evaluation as antiplasmodial agents
-
Synthesis and Antimalarial evaluation of Gold Thiosemicarbazone Complexes and Polyamine-Thiosemicarbazone Dendrimers
-
Repurposing chlorpromazine and its metabolites for antituberculosis drug discovery
-
A medicinal chemistry approach to drug repositioning in the treatment of tuberculosis and malaria
-
Repositioning fusidic acid for tuberculosis: semi-synthesis of analogues and impact of mycobacterial biotransformation on antibiotic activity
-
Antiprotozoal quinolines containing electrophilic moieties
-
Novel Antimalarial and Antitubercular Agents Based on Natural Products
-
Isolation and characterization of African marine natural products and repositioning of the natural product antibiotic fusidic acid and privileged benzimidazole scaffold for tuberculosis and malaria
-
Synthesis and evaluation of hybrid compounds based on antimalarial and anticancer pharmacophores
-
Exploring the potential of xanthene derivatives as inhibitors of trypanothione reductase and resistance reversal agents
-
Investigating the chemical space and metabolic bioactivation of natural products and cross-reactivity of chemical inhibitors in CYP450 phenotyping
-
Ferrocenic metal chelators : synthesis, biological and electrochemical studies
-
Piperazine-based pyrido[1,2-a]benzimidazoles: synthesis and pharmacological evaluation as potential antimalarial and antischistosomal agents
-
Bioactive chloroquine-based ligands and their gold complexes as potential novel antimalarial agents
-
Synthesis and evaluation of D-cycloserine analogues against mycobacterium tuberculosis
-
Antimalarial drug rescue through safety improvement: design, synthesis and evaluation of amaodiaquine analogues
-
Developing methods to prioritize in vitro drug combinations against Mycobacterium tuberculosis: fusidic acid as potential combination partner with known antitubercular agents
